Track Acurx Pharmaceuticals's current assets ($11M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Acurx Pharmaceuticals (ACXP) currently reports a current assets of $11M as of June 2026. That compares with $6.1B in the prior-year period — down 99.8% year over year. Use the charts on this page to explore Acurx Pharmaceuticals's current assets history and peer comparisons.
Acurx Pharmaceuticals's current assets decreased from $6.1B to $11M — a 99.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Acurx Pharmaceuticals reported $11M in current assets as of June 2026. That compares with $6.1B in the prior-year period — down 99.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acurx Pharmaceuticals, and consider following ACXP for alerts when major investors trade the stock.
Acurx Pharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACXP with unrelated industries.